| Bioactivity | CPN-219, a next-generation hexapeptidic NMUR2 agonist, achieves a dose-dependent and selective activation of NMUR2 with an EC50 value of 2.2 nM[1]. |
| In Vivo | Animal Model: |
| CAS | 2240202-02-0 |
| Sequence | {3-Cyclohexylpropionyl}-Leu-Leu-{Dbu}-Pro-Arg-Asn-NH2 |
| Shortening | {3-Cyclohexylpropionyl}-LL-{Dbu}-PRN-NH2 |
| Formula | C40H72N12O8 |
| Molar Mass | 849.08 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kentaro Takayama, et al. A chemically stable peptide agonist to neuromedin U receptor type 2. Bioorg Med Chem. 2020 May 15;28(10):115454. |